ENTEROMEDICS INC. (NASDAQ:ETRM) Files An 8-K Financial Statements and ExhibitsItem 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
The audited financial statements of BarioSurg as of and for the years ended December31, 2016 and December31, 2015 and the unaudited interim financial statements of BarioSurg as of and for the three months ended March31, 2017 are filed as Exhibit99.1 and Exhibit99.2, respectively, and are incorporated by reference.
(b) Pro Forma Financial Information.
The unaudited pro forma balance sheet as of March31, 2017 and unaudited pro forma statements of income for the three months ended March31, 2017 and the year ended December31, 2016 and the notes to such unaudited pro forma financial statements, all giving effect to the Merger, are filed as Exhibit99.3 and incorporated by reference.
(c) Shell Company Information.
Not applicable.
(d) Exhibits.
ExhibitNo. |
Description |
23.1 |
Consent of KCCW Accountancy Corp., independent registered public accounting firm for BarioSurg,Inc. |
99.1 |
Audited financial statements of BarioSurg,Inc. as of and for the years ended December31, 2016 and December31, 2015 |
99.2 |
Unaudited financial statements of BarioSurg,Inc. as of and for the three months ended March31, 2017 |
99.3 |
Unaudited pro forma financial statements of EnteroMedics Inc. |
Important Additional Information and Where to Find It
The Company intends to file a proxy statement and other relevant materials with the SEC to obtain approval from the Company’s stockholders of the conversion of the conditional convertible preferred stock of EnteroMedics issued to BarioSurg’s stockholders in connection with the acquisition into shares of common stock of EnteroMedics (the “Stockholder Approval”).INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHER